Metabolic-Bariatric Surgery Tied to Reduced Risk for Pancreatic Cancer in Those With Obesity HealthDay
Source link
Related posts:
- 404 – Page Not Found It is possible that you used an outdated or expired MedicineNet link or typed the […] ...
- Most Johns Hopkins Med Students Will Receive Free Tuition, Thanks to $1 Billion Gift Most medical students at Johns Hopkins University will no longer pay tuition, thanks to a […] ...
- Are your dental job postings attracting narcissists? Certain terms in job listings attract narcissists who are likely to be ‘unethical’ or even […] ...
- Targeted drug can ‘diminish the suffering’ of myelofibrosis Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a researcher who co-led PERSIST-1, the worldwide phase 3 clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent. ...
- As Record Heat Sweeps the US, Some People Must Choose Between Food and Energy Bills CHARLOTTE, N.C. — During the heat dome that blanketed much of the Southeast in June, […] ...
